SeaStar Medical Holding Corp 8-K

What Happened
SeaStar Medical Holding Corporation filed a Form 8-K dated June 17, 2026, reporting that at its Annual Meeting on June 17, 2026, stockholders approved an amendment and restatement of the company’s 2022 Omnibus Incentive Plan. The amendment increases the number of authorized shares of common stock available under the 2022 Equity Incentive Plan from 207,046 shares to 896,546 shares. A summary of the plan was included in the company’s definitive proxy statement filed April 29, 2026; the amended and restated plan is filed as Exhibit 10.1 to the 8‑K.

Key Details

• Vote occurred at the Annual Meeting on June 17, 2026.
• Authorized shares under the 2022 Equity Incentive Plan increased from 207,046 to 896,546 common shares.
• Proxy summary with plan details filed April 29, 2026; the full amended plan is attached as Exhibit 10.1 to the 8‑K.

Why It Matters
Approving the increase gives SeaStar the ability to grant substantially more stock-based awards (options, restricted stock, etc.) to employees, directors and consultants under the 2022 plan, supporting compensation, retention and recruitment programs. If and when new awards are issued, they would increase the company’s outstanding share count and could be dilutive to existing shareholders’ ownership percentages and per-share metrics. Investors should watch future disclosures for actual grant activity and any changes to share count.